C-Path’s Translational Therapeutics Accelerator Announces 2026 Request for Proposals from Academic Investigators Included is a dedicated polycystic kidney disease track alongside investments in brain health, pediatrics, and rare diseases. TUCSON, Ariz., January 21, 2026 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator today officially launched its 2026 global Request for…
The start of the new year has been busy with activity in the health policy world. ACIP has continued to narrow vaccine recommendations, with hepatitis A and B, rotavirus, influenza, meningococcal, and RSV vaccines no longer routinely recommended. The Affordable Care Act premium subsidies were allowed to expire at the…
This request for applications is to provide pilot funding to early-stage investigators in the PKD field and established investigators who are new to PKD research. About The Polycystic Kidney Disease Research Resource Consortium (PKD RRC) The goal of the PKD RRC (pkd-rrc.org) is to accelerate discovery in the field of…
Composed of over 21,000 physicians and scientists, ASN is the world’s largest professional society devoted to the study of kidney disease. ASN holds several programs to expand and support the nephrology workforce, including Kidney Tutored Research and Education for Kidney Scholars (TREKS). Kidney TREKS fosters an interest in nephrology through a…
Dr. Drake is a pediatric nephrologist at UT Southwestern Medical Center. Her research focuses on using genetically engineered mouse models to understand how disruptions in normal kidney development drive Wilms tumorigenesis. Given that the underlying mechanisms of how Wilms tumors originate from renal progenitor cells and can “hijack” developmental programs…
I’m sure we are all aware of the CDC’s Advisory Committee on Immunization Practices’ (ACIP) vote to revoke its long-standing recommendation that all newborns receive a hepatitis B vaccination within 24 hours of birth. This decision is sadly expected to lead to a resurgence of a disease which was nearly…
We are pleased to announce that registration is now open for the upcoming cohort of the ASPN Mentorship Program—a society-wide initiative designed to foster meaningful professional growth, connection, and leadership within pediatric nephrology. This structured program brings together ASPN members across career stages to support mentorship relationships that promote career…
I am so excited and honored to be writing you all as one of the new JELF Scholars! Although I have only recently joined, I can already feel the great impacts of being part of such a driven group of people. I recently had my first experience with a virtual…
The Living Donor Protection Act (LDPA) has been reintroduced in the House and Senate. It is critical for ASPN members to reach out to your congressional delegation to share how important the LDPA is to your patients and their donors and ask that they cosponsor the legislation. The LDPA (H.R.4583)…
JELF Scholars are well on their way in growing in their advocacy and integrating this into their care for children with kidney disease. Meet the new 2025 scholars here! I am Stephanie Kerkvliet, a pediatric nephrologist at the Children’s Hospital of Philadelphia. My areas of interest include improving access and…
